Your browser doesn't support javascript.
loading
Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial.
Mukherjee, Somnath; Hurt, Christopher; Radhakrishna, Ganesh; Gwynne, Sarah; Bateman, Andrew; Gollins, Simon; Hawkins, Maria A; Canham, Joanne; Grabsch, Heike I; Falk, Stephen; Sharma, Ricky A; Ray, Ruby; Roy, Rajarshi; Cox, Catrin; Maynard, Nick; Nixon, Lisette; Sebag-Montefiore, David J; Maughan, Timothy; Griffiths, Gareth O; Crosby, Tom D L.
Afiliación
  • Mukherjee S; Oxford Institute for Radiation Oncology, Oxford University, Oxford, OX3 7DQ, UK; Department of Oncology, Oxford University Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 7LE, UK.
  • Hurt C; Centre for Trials Research, Cardiff University, Cardiff, CF14 4YS, UK. Electronic address: hurtcn@cardiff.ac.uk.
  • Radhakrishna G; Christie Hospital, Christie NHS Foundation Trust, Manchester, M20 4BX, UK.
  • Gwynne S; South West Wales Cancer Centre, Singleton Hospital, Swansea Bay University Health Board, Swansea, SA2 8QA, UK.
  • Bateman A; Clinical Oncology, University Hospital Southampton, Southampton, SO16 6YD, UK.
  • Gollins S; North Wales Cancer Treatment Centre, Betsi Cadwaladr University Health Board, Rhyl, LL18 5UJ, UK.
  • Hawkins MA; Cancer Institute, University College London, London, WC1E 6DD, UK.
  • Canham J; Centre for Trials Research, Cardiff University, Cardiff, CF14 4YS, UK.
  • Grabsch HI; Department of Pathology, Maastricht University Medical Center, Maastricht, the Netherlands; Leeds Institute of Medical Research, University of Leeds, Leeds, LS9 7TF, UK.
  • Falk S; Bristol Haematology and Oncology Centre, University Hospitals Bristol, Bristol, BS2 8ED, UK.
  • Sharma RA; Cancer Institute, University College London, London, WC1E 6DD, UK.
  • Ray R; Centre for Trials Research, Cardiff University, Cardiff, CF14 4YS, UK.
  • Roy R; Castle Hill Hospital, Hull University Teaching Hospitals NHS Trust, Hull, HU16 5JQ, UK.
  • Cox C; Centre for Trials Research, Cardiff University, Cardiff, CF14 4YS, UK.
  • Maynard N; Department of Oncology, Oxford University Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 7LE, UK.
  • Nixon L; Centre for Trials Research, Cardiff University, Cardiff, CF14 4YS, UK.
  • Sebag-Montefiore DJ; Leeds Institute of Medical Research, University of Leeds, Leeds, LS9 7TF, UK.
  • Maughan T; Oxford Institute for Radiation Oncology, Oxford University, Oxford, OX3 7DQ, UK.
  • Griffiths GO; Southampton Clinical Trials Unit, University of Southampton, Southampton, SO16 6YD, UK.
  • Crosby TDL; Velindre Cancer Centre, Velindre University NHS Trust, Cardiff, CF14 2TL, UK.
Eur J Cancer ; 153: 153-161, 2021 08.
Article en En | MEDLINE | ID: mdl-34157617
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Esofágicas / Adenocarcinoma / Carboplatino / Paclitaxel / Quimioradioterapia Adyuvante / Capecitabina / Oxaliplatino Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male Idioma: En Revista: Eur J Cancer Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Esofágicas / Adenocarcinoma / Carboplatino / Paclitaxel / Quimioradioterapia Adyuvante / Capecitabina / Oxaliplatino Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male Idioma: En Revista: Eur J Cancer Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido